Assessment of cytotoxicity of an original industrial aerosol containing a high percentage of amorphous silica in the nanometer range

Cover Page

Cite item

Full Text

Abstract

Introduction. At the current stage of hygienic evaluation, the substantiation of at least approximate safe concentrations in the ambient air of populated areas for nanoparticles is an up-to-date challenge. Its persistence dissolves the guidelines for risk management and divests the supervisory bodies of legal support. A comparative toxicological evaluation of the studied substance and its chemical analogue is one of the guidelines for the academic substantiation of the hygienic standards for the permissible content of hazardous substances in the air. It already has previously defined exposure standards.

Materials and methods. To investigate the cytotoxicity of the studied particles, a shift of the cellular composition of the bronchoalveolar lavage fluid (BALF) was used. Also, some biochemical measurements of the BALF supernatant were investigated. Outbred female rats were instilled with a suspension of particles in the volume of 1 ml of various concentrations in the form of an intratracheal suspension. Distilled water was used as a solvent. Statistical analysis of the data obtained was performed using the Student’s t-test.

Results. The comparative assessment of the cytotoxicity of an original industrial aerosol containing 72% amorphous silica with an average particle size of 90 nm (SiO2 IA) was performed. It also included engineered particles of amorphous silica with an average size of 43 nm (SiO2 NPs), a commercial, an industrial sample of 100% amorphous silica with a particle size of 5 to 60 nm (amorphous SiO2), and a reference sample of standard quartz DQ12 in a volume of 1 ml of water suspension. Under the findings of changes in the cellular composition of the bronchoalveolar lavage fluid 24 hours after the intratracheal instillation of these particles, it was revealed that the biological power (in terms of the NL/AM ratio) of both SiO2 NPs and amorphous SiO2 is statistically much higher than the industrial aerosol under study. It is also higher than the standard quartz dust DQ12. In this regard, the cytotoxicity of SiO2 IA may be explained by the predominant content of amorphous silica nanoparticles in it.

Conclusion. Under the obtained results, the appropriateness of using indicative safe exposure levels (ISEL) of 0.02 mg/m3 for amorphous silica needs to be reviewed. The safe reference level of impact guideline does not contain data concerning the particle size and the percentage of amorphous SiO2 in the aerosol. Nevertheless, it is impossible to pollute the ambient air with an aerosol containing only this substance. 

Contribution:

Solovyеva S.N. — collection and processing of material;

Sutunkova M.P. — the concept and design of the study, writing;

Kuzmin S.V. — the concept and design of the study;

Privalova L.I. — the concept and design of the study, editing;

Gurvich V.B. — the concept and design of the study;

Katsnelson B.A. — concept and design of the study.

All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.

Conflict of interest. The authors declare no conflict of interest.

Acknowledgement. The study had no sponsorship.

 

About the authors

Svetlana N. Solovyeva

Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

Author for correspondence.
Email: solovyevasn@ymrc.ru
ORCID iD: 0000-0001-8580-403X

MD, researcher, Department of the Experimental Animals, Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, Yekaterinburg, 620014, Russian Federation.

e-mail: solovyevasn@ymrc.ru

Russian Federation

Marina P. Sutunkova

Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

Email: noemail@neicon.ru
ORCID iD: 0000-0002-1743-7642
Russian Federation

Sergey V. Kuzmin

Federal Scientific Center of Hygiene named after F. Erisman, Federal Service for Supervision of Consumer Rights Protection and Human Welfare

Email: noemail@neicon.ru
ORCID iD: 0000-0002-9119-7974
Russian Federation

Larisa I. Privalova

Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

Email: noemail@neicon.ru
ORCID iD: 0000-0002-1442-6737
Russian Federation

Vladimir B. Gurvich

Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

Email: noemail@neicon.ru
ORCID iD: 0000-0002-6475-7753
Russian Federation

Boris A. Katsnelson

Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

Email: noemail@neicon.ru
ORCID iD: 0000-0001-8750-9624
Russian Federation

References

  1. Vance M.E., Kuiken T, Vejerano E.P., McGinnis S.P., Hochella M.F., Rejeski D., et al. Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory. Beilstein J. Nanotechnol. 2015; 6: 1769–80. https://doi.org/10.3762/bjnano.6.181
  2. Park E.J., Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 2009; 184(1): 18–25. https://doi.org/10.1016/j.toxlet.2008.10.012
  3. Eom H.J., Choi J. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. Toxicol. In Vitro. 2009; 23(7): 1326–32. https://doi.org/10.1016/j.tiv.2009.07.010
  4. Kim J.H., Kim C.S., Ignacio R.M., Kim D.H., Sajo M.E., Maeng E.H., et al. Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge. Int. J. Nanomedicine. 2014; 9(Suppl. 2): 183–93. https://doi.org/10.2147/ijn.s57934
  5. Sergent J.A., Paget V., Chevillard S. Toxicity and genotoxicity of nano-SiO2 on human epithelial intestinal HT-29 cell line 48. Ann. Occup. Hyg. 2012; 56(5): 622–30. https://doi.org/10.1093/annhyg/mes005
  6. Du Z., Zhao D., Jing L., Cui G., Jin M., Li Y., Liu X., et al. Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation. Cardiovasc. Toxicol. 2013; 13(3): 194–207. https://doi.org/10.1007/s12012-013-9198-y
  7. Zemlyanova M.A., Zvezdin V.N., Dovbysh A.A., Akaf’eva T.I. Comparison of toxicity of aqueous suspension of nano- and microfine silica in subchronic experiment. Analiz riska zdorov’yu. 2014; (1): 74–82. (in Russian)
  8. Zaytseva N.V., Zemlyanova M.A., Zvezdin V.N., Dovbysh A.A., Gmoshinskiy I.V., Khotimchenko S.A. Impact of silica dioxide nanoparticles on the morphology of internal organs in rats by oral supplementation. Analiz riska zdorov’yu. 2016; (4): 80–94. https://doi.org/10.21668/health.risk/2016.4.10 (in Russian)
  9. Shumakova A.A., Arianova E.A., Shipelin V.A., Sidorova Yu.S., Selifanov A.V., Trushina E.N., et al. Toxicological assessment of nanostructured silica. I. Integral indices, adducts of DNA, tissue thiols and apoptosis in liver. Voprosy pitaniya. 2014; 83(3): 52–62. (in Russian)
  10. Shumakova A.A., Avren’eva L.I., Guseva G.V., Kravchenko L.V., Soto S.Kh., Vorozhko I.V., et al. Toxicological assessment of nanostructured silica. II. Enzymatic, biochemical indices, state of antioxidative defence. Voprosy pitaniya. 2014; 83(4): 58–66. (in Russian)
  11. Shumakova A.A., Efimochkina N.R., Minaeva L.P., Bykova I.B., Batishcheva S.Yu., Markova Yu.M., et al. Toxicological assessment of nanostructured silica. III. Microecological, hematological indices, state of cellular immunity. Voprosy pitaniya. 2015; 84(4): 55–65. (in Russian)
  12. Petrick L., Rosenblat M., Paland N., Aviram M. Silicon dioxide nanoparticles increase macrophage atherogenicity: Stimulation of cellular cytotoxicity, oxidative stress, and triglycerides accumulation. Environ. Toxicol. 2014; 31(6): 713–23. https://doi.org/10.1002/tox.22084
  13. Guo H., Callaway J.B., Ting J.P. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 2015; 21(7): 677–87. https://doi.org/10.1038/nm.3893
  14. Wang W., Li Y., Liu X., Jin M., Du H., Liu Y., et al. Multinucleation and cell dysfunction induced by amorphous silica nanoparticles in an L-02 human hepatic cell line. Int. J. Nanomedicine. 2013; 8: 3533–41. https://doi.org/10.2147/ijn.s46732
  15. Velichkovskiy B.T., Katsnel’son B.A. Etiology and Pathogenesis of Silicosis [Etiologiya i patogenez silikoza]. Moscow: Meditsina; 1964. (in Russian)
  16. Katsnel’son B.A., Alekseeva O.G., Privalova L.I., Polzik E.V. Pneumoconiosis: Pathogenesis and Biological Prevention [Pnevmokoniozy: patogenez i biologicheskaya profilaktika]. Ekaterinburg; 1995. (in Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Solovyeva S.N., Sutunkova M.P., Kuzmin S.V., Privalova L.I., Gurvich V.B., Katsnelson B.A.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 37884 от 02.10.2009.